½ÃÀ庸°í¼­
»óǰÄÚµå
1600182

±¤À½Çâ À̹Ì¡ ½ÃÀå : Á¦Ç° À¯Çü, ¸ð´Þ¸®Æ¼, Áø´Ü ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Photoacoustic Imaging Market by Product Type (Components, Contrast Agents, Imaging Systems), Type (Clinical, Pre-Clinical), Modality, Diagnostic Application, End-User, Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±¤À½Çâ À̹Ì¡ ½ÃÀåÀº 2023³â¿¡ 8,939¸¸ USD·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 9,394¸¸ USD¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.42%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1¾ï 2,936¸¸ USD°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±¤À½Çâ À̹Ì¡(PAI)Àº ·¹ÀÌÀú À¯µµ ÃÊÀ½ÆÄ¸¦ ÀÌ¿ëÇÏ¿© »ýü Á¶Á÷ÀÇ ³»ºÎ ±¸Á¶¸¦ ½Ã°¢È­ÇÏ´Â »õ·Î¿î »ýÀÇÇÐ À̹Ì¡ ±â¼úÀÔ´Ï´Ù. PAIÀÇ Çʿ伺Àº ºñÀ̿¼º, ½Ç½Ã°£ ºÐÀÚ º¯È­¸¦ ½Ã°¢È­ÇÏ´Â ´É·Â, ƯÈ÷ Á¾¾çÇÐ, ½ÉÀ庴ÇÐ, ½Å°æÇÐ ºÐ¾ß¿¡¼­ Áúº´ÀÇ Á¶±â ¹ß°ß °¡´É¼º¿¡ ±âÀÎÇÕ´Ï´Ù. KEYWORDÀÇ ¿ëµµ´Â ÀüÀÓ»ó ¿¬±¸, ÀÓ»ó Áø´Ü, Ä¡·á ¹ÝÀÀ ¸ð´ÏÅ͸µ, ¼ö¼ú Áß ¾È³» µî ´Ù¾çÇÑ ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â º´¿ø, Çмú±â°ü, ¿¬±¸¼Ò µî ¿µ»ó Áø´ÜÀÇ Á¤È®¼ºÀ» ³ôÀ̰í ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇϰíÀÚ ÇÏ´Â ¸ðµç ±â°ü¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 8,939¸¸ ´Þ·¯
¿¹Ãø³â[2024] 9,394¸¸ ´Þ·¯
¿¹Ãø³â[2030] 1¾ï 2,936¸¸ ´Þ·¯
CAGR(%) 5.42%

PAI ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ·¹ÀÌÀú ¹× ÃÊÀ½ÆÄ ±â¼úÀÇ ±â¼úÀû ¹ßÀü, ¿¬±¸°³¹ß ÀÚ±Ý Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. Á¾¾çÀÇ ´ÜÀý°ú ÀüÀ̸¦ ³ôÀº Á¤È®µµ·Î ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, Á¾¾çÇÐ ºÐ¾ß¿¡¼­ Å« ¼ö¿ä°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î´Â ³ôÀº ±â±â ºñ¿ë, PAI¿Í ±âÁ¸ ÇコÄÉ¾î ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀÇ º¹À⼺, ½Ã½ºÅÛ °£ Ç¥ÁØÈ­ ºÎÁ· µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÏ»ó Áø·á¿¡¼­ PAIÀÇ À¯È¿¼ºÀ» Áö¿øÇÏ´Â ÀÓ»ó µ¥ÀÌÅͰ¡ Á¦ÇÑÀûÀÌ°í °³¹ßµµ»ó±¹¿¡¼­ÀÇ ÀÎÇÁ¶ó Á¦¾àµµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

±âȸ´Â ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ½Ã½ºÅÛÀ» °³¹ßÇϱâ À§ÇÑ ¾÷°è¿Í ¿¬±¸±â°üÀÇ Çù·Â, ÇǺΰú ¹× ½ÉÇ÷°ü ¿µ»ó Áø´ÜÀÇ ¿ëµµ È®´ë, Àç·á °Ë»ç ¹× º¸¾È °Ë»ç¿Í °°Àº ºñ»ýü ÀÇÇÐ ¿ëµµ Ž»ö¿¡ ÀÖ½À´Ï´Ù. ¿µ»ó ±íÀÌ¿Í ÇØ»óµµ Çâ»ó, È޴뼺À» ³ôÀ̱â À§ÇÑ ½Ã½ºÅÛ Å©±â Ãà¼Ò, ÀÚµ¿ À̹ÌÁö ºÐ¼®À» À§ÇÑ ÀΰøÁö´É ÅëÇÕ µî ±â¼ú Çõ½ÅÀÇ ¿©Áö°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ÁýÁßÇÔÀ¸·Î½á ¾÷°è °ü°èÀÚµéÀº º¯È­ÇÏ´Â ½ÃÀå ȯ°æ¿¡¼­ Å« Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±¤À½Çâ À̹Ì¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±¤À½Çâ À̹Ì¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¾Ï ¹× ½ÉÇ÷°ü°è ÁúȯÀ» °¨ÁöÇϱâ À§ÇÑ Ã·´Ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ±âÁ¸ÀÇ Ä§½ÀÀû Áø´Ü¹ýº¸´Ù ºñħ½ÀÀû Áø´Ü¹ý¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
    • ÇコÄÉ¾î ºÐ¾ß ¹ßÀüÀ» °¡¼ÓÈ­Çϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»ó
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº Àåºñ ºñ¿ë, ÀÇ·áÁøÀÇ ³·Àº Àνİú Àü¹® Áö½Ä
  • ½ÃÀå ±âȸ
    • »õ·Î¿î ÀÇ·á¿ë ¿ëµµ¸¦ Ãâ½ÃÇϱâ À§ÇÑ R&D ÅõÀÚ Áõ°¡.
    • »õ·Ó°í Áøº¸µÈ ±¤À½Çâ À̹Ì¡ ±â¼ú °³¹ß
  • ½ÃÀå °úÁ¦
    • ¾ö°ÝÇÏ°í ½Ã°£ÀÌ ¿À·¡ °É¸®´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ÀýÂ÷

Portre's Five Forces: ±¤À½Çâ À̹Ì¡ ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±¤À½Çâ À̹Ì¡ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±¤À½Çâ À̹Ì¡ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±¤À½Çâ À̹Ì¡ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±¤À½Çâ À̹Ì¡ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

±¤À½Çâ À̹Ì¡ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±¤À½Çâ À̹Ì¡ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±¤À½Çâ À̹Ì¡ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±¤À½Çâ À̹Ì¡ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

±¤À½Çâ À̹Ì¡ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÄÄÆ÷³ÍÆ®
  • Á¶¿µÁ¦
  • À̹Ì¡ ½Ã½ºÅÛ
  • ·¹ÀÌÀú
  • ¼ÒÇÁÆ®¿þ¾î
  • Æ®·£½ºµà¼­

Á¦7Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : À¯Çüº°

  • ÀÓ»ó
  • ÀüÀÓ»ó

Á¦8Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ÇÚµåÇïµå
  • ÈÞ´ë¿ë
  • ½ºÅĵå¾ó·Ð

Á¦9Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : Áø´Ü ¾ÖÇø®ÄÉÀ̼Ç

  • ½ÉÀ庴ÇÐ
  • ÇǺΰú
  • Ç÷¾×ÇÐ
  • ½Å°æÇÐ
  • Á¾¾çÇÐ

Á¦10Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • º´¿ø°ú Áø·á¼Ò
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Á¶»ç½Ç

Á¦11Àå ±¤À½Çâ À̹Ì¡ ½ÃÀå : À¯Åë ä³Îº°

  • Á÷Á¢ ÀÔÂû
  • ¿Â¶óÀÎ ÆÇ¸Å
  • ¼Ò¸Å ÆÇ¸Å

Á¦12Àå ¾Æ¸Þ¸®Ä«ÀÇ ±¤À½Çâ À̹Ì¡ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±¤À½Çâ À̹Ì¡ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦14Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±¤À½Çâ À̹Ì¡ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Aspectus GmbH
  • Canon Inc.
  • CYBERDYNE, INC.
  • Endra Life Sciences Inc.
  • Fujifilm Corporation
  • GE HealthCare Technologies, Inc.
  • Global Life Sciences Solutions
  • Hitachi Ltd.
  • illumiSonics Inc.
  • IMEC Inc.
  • InnoLas Laser GmbH
  • iThera Medical GmbH
  • Kibero GmbH
  • PA Imaging R&D B.V.
  • PhotoSound Technologies, Inc.
  • PreXion Inc.
  • Seno Medical Instruments, Inc.
  • Siemens Healthineers AG
  • Teratech Corporation
  • TomoWave Laboratories, Inc.
  • Vibronix Inc.
KSA 24.12.03

The Photoacoustic Imaging Market was valued at USD 89.39 million in 2023, expected to reach USD 93.94 million in 2024, and is projected to grow at a CAGR of 5.42%, to USD 129.36 million by 2030.

Photoacoustic imaging (PAI) is an emerging biomedical imaging technique that utilizes laser-induced ultrasound waves to visualize the internal structures of biological tissues. This hybrid modality leverages the high contrast and specificity of optical imaging with the deep tissue penetration of ultrasound, providing detailed insights into tissue composition and function. The necessity for PAI stems from its non-ionizing nature, capability to visualize real-time molecular changes, and potential for early disease detection, notably in the fields of oncology, cardiology, and neurology. The application of photoacoustic imaging spans various sectors, including preclinical research, clinical diagnostics, monitoring therapy response, and intraoperative guidance. Its end-use scope encompasses hospitals, academic institutions, and research laboratories, which are keen on enhancing imaging precision and improving patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 89.39 million
Estimated Year [2024] USD 93.94 million
Forecast Year [2030] USD 129.36 million
CAGR (%) 5.42%

Key growth factors for the PAI market include technological advancements in laser and ultrasound technologies, increased funding for research and development, and growing awareness about early disease detection. There's a significant demand in oncology for its ability to identify tumor margins and metastases with high accuracy. However, the challenges restraining market growth include high costs associated with the equipment, the complexity of integrating PAI with existing healthcare systems, and a lack of standardization across systems. Additionally, limited clinical data supporting the efficacy of PAI in routine practice and infrastructural constraints in developing regions pose further hindrances.

Opportunities lie in collaborations between industry players and research institutions to develop cost-effective and user-friendly systems, expansion of applications in dermatology and cardiovascular imaging, and exploring non-biomedical applications such as material inspection and security screening. There's room for innovation in enhancing the depth and resolution of imaging, reducing system size for better portability, and integrating artificial intelligence for automated imaging analysis. By focusing on these areas, industry stakeholders can capture a significant market share in the evolving landscape of photoacoustic imaging technology.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Photoacoustic Imaging Market

The Photoacoustic Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for advanced imaging techniques in detecting cancers, cardiovascular issues
    • Rising favor of non-invasive diagnostic methods over traditional invasive techniques
    • Government initiatives to accelerate the advancement in the healthcare sector
  • Market Restraints
    • High cost of the equipment and limited awareness and expertise among medical professionals
  • Market Opportunities
    • Increasing investment in research and development to launch new medical applications
    • Development of novel and advanced photoacoustic Imaging technology
  • Market Challenges
    • Rigorous and time-consuming regulatory approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Photoacoustic Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Photoacoustic Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Photoacoustic Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Photoacoustic Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Photoacoustic Imaging Market

A detailed market share analysis in the Photoacoustic Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Photoacoustic Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Photoacoustic Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Photoacoustic Imaging Market

A strategic analysis of the Photoacoustic Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Photoacoustic Imaging Market, highlighting leading vendors and their innovative profiles. These include Aspectus GmbH, Canon Inc., CYBERDYNE, INC., Endra Life Sciences Inc., Fujifilm Corporation, GE HealthCare Technologies, Inc., Global Life Sciences Solutions, Hitachi Ltd., illumiSonics Inc., IMEC Inc., InnoLas Laser GmbH, iThera Medical GmbH, Kibero GmbH, PA Imaging R&D B.V., PhotoSound Technologies, Inc., PreXion Inc., Seno Medical Instruments, Inc., Siemens Healthineers AG, Teratech Corporation, TomoWave Laboratories, Inc., and Vibronix Inc..

Market Segmentation & Coverage

This research report categorizes the Photoacoustic Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Components, Contrast Agents, Imaging Systems, Lasers, Software, and Transducers.
  • Based on Type, market is studied across Clinical and Pre-Clinical.
  • Based on Modality, market is studied across Handheld, Portable, and Standalone.
  • Based on Diagnostic Application, market is studied across Cardiology, Dermatology, Hematology, Neurology, and Oncology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Research Laboratories.
  • Based on Distribution Channel, market is studied across Direct Tender, Online Sales, and Retail Sales.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for advanced imaging techniques in detecting cancers, cardiovascular issues
      • 5.1.1.2. Rising favor of non-invasive diagnostic methods over traditional invasive techniques
      • 5.1.1.3. Government initiatives to accelerate the advancement in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the equipment and limited awareness and expertise among medical professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in research and development to launch new medical applications
      • 5.1.3.2. Development of novel and advanced photoacoustic Imaging technology
    • 5.1.4. Challenges
      • 5.1.4.1. Rigorous and time-consuming regulatory approval processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising popularity of photoacoustic imaging for improving patient care and effective diagnostic
    • 5.2.2. Application: Significant use of photoacoustic imaging in cardiology application to create detailed images of anatomical structures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Photoacoustic Imaging Market, by Product Type

  • 6.1. Introduction
  • 6.2. Components
  • 6.3. Contrast Agents
  • 6.4. Imaging Systems
  • 6.5. Lasers
  • 6.6. Software
  • 6.7. Transducers

7. Photoacoustic Imaging Market, by Type

  • 7.1. Introduction
  • 7.2. Clinical
  • 7.3. Pre-Clinical

8. Photoacoustic Imaging Market, by Modality

  • 8.1. Introduction
  • 8.2. Handheld
  • 8.3. Portable
  • 8.4. Standalone

9. Photoacoustic Imaging Market, by Diagnostic Application

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Dermatology
  • 9.4. Hematology
  • 9.5. Neurology
  • 9.6. Oncology

10. Photoacoustic Imaging Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals and Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies
  • 10.6. Research Laboratories

11. Photoacoustic Imaging Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Direct Tender
  • 11.3. Online Sales
  • 11.4. Retail Sales

12. Americas Photoacoustic Imaging Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Photoacoustic Imaging Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Photoacoustic Imaging Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Caltech's breakthrough in photoacoustic imaging of offer cost-effective and simplified technology
    • 15.3.2. Seno Medical's Imagio Breast Imaging System with photoacoustic technology gains global standard recognition in the DICOM 2023c update
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aspectus GmbH
  • 2. Canon Inc.
  • 3. CYBERDYNE, INC.
  • 4. Endra Life Sciences Inc.
  • 5. Fujifilm Corporation
  • 6. GE HealthCare Technologies, Inc.
  • 7. Global Life Sciences Solutions
  • 8. Hitachi Ltd.
  • 9. illumiSonics Inc.
  • 10. IMEC Inc.
  • 11. InnoLas Laser GmbH
  • 12. iThera Medical GmbH
  • 13. Kibero GmbH
  • 14. PA Imaging R&D B.V.
  • 15. PhotoSound Technologies, Inc.
  • 16. PreXion Inc.
  • 17. Seno Medical Instruments, Inc.
  • 18. Siemens Healthineers AG
  • 19. Teratech Corporation
  • 20. TomoWave Laboratories, Inc.
  • 21. Vibronix Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦